COMP <GO>
WOOF vs TSLA // EV/EBITDA & P/E VALUATION
Petco Health and Wellness Company Inc. (Class A) (NASDAQ) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: WOOF 5
— TSLA 5
▲ EV/EBITDA & P/E VALUATION LEADER: WOOF
LAST: $2.59 (+3.19%) • MKT CAP: $741.8M
valuation
8.6x
LAST: $403.30 (-0.23%) • MKT CAP: $1.59T
valuation
199.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WOOF VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WOOF | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.70% | 19.29% | +19.41 | WOOF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.00% | 3.39% | +0.61 | WOOF | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 8.6x | 199.0x | -190.44 | WOOF | /valuation <GO> |
| Free Cash Flow Yield | — | 0.21% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 2.00% | 3.35% | -1.35 | TSLA | /operating-margins <GO> |
| Net Profit Margin | 0.20% | 3.11% | -2.91 | TSLA | /net-margins <GO> |
| Revenue Growth (YoY) | -2.50% | 8.30% | -10.80 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.01 | 15.35 | -14.34 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | WOOF | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 8.72% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.6 | 56.6 | +8.97 | WOOF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 75.8x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $741.8M | $1.59T | -$1.59T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WOOF REV | TSLA REV | WOOF GROSS % | TSLA GROSS % | WOOF FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.96B | $94.83B | 38.7% | 18.0% | $187.0M | $6.22B |
| FY 2024 | $6.12B | $97.69B | 38.0% | 17.9% | $49.7M | $3.58B |
| FY 2023 | $6.26B | $96.77B | — | 18.3% | $215.7M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WOOF // BETA —
TSLA // BETA 1.89